HCPLive
MARCH 13, 2024
In a registry-based analysis, more hospitalized children with SCD and COVID-19 had severe infection requiring supplemental oxygen, compared with the general population.
Med Page Today
MARCH 13, 2024
(MedPage Today) -- Note that some links may require registration or subscription. These types of medications don't mix well with driving, the FDA warned. About 11% of high school seniors reported using delta-8-tetrahydrocannabinol (delta-8-THC.
DAIC
MARCH 13, 2024
Getty Images milla1cf Wed, 03/13/2024 - 16:49 March 13, 2024 — BioCardia, Inc. , a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced Centers for Medicare & Medicaid Services (CMS) approval for reimbursement coverage of the confirmatory Phase III clinical trial of CardiAMP autologous cell therapy for the treatment of patients with ischemic heart failure.
Med Page Today
MARCH 13, 2024
(MedPage Today) -- Liraglutide (Victoza), a type 2 diabetes drug, may help prevent peripheral artery disease (PAD) progression, the small, open-label STARDUST trial suggested. Over 6 months, adults with type 2 diabetes on subcutaneous liraglutide.
Cardiovascular Diabetology
MARCH 13, 2024
The association of the triglyceride-glucose (TyG) index with intracranial atherosclerotic stenosis (ICAS) and extracranial atherosclerotic stenosis (ECAS) is unclear. This study aimed to investigate the relati.
DAIC
MARCH 13, 2024
Silence Therapeutics has announces positive topline 36-week data from its ongoing Phase 2 Study of Zerlasiran in patients with high Lipoprotein(a), reporting that the study met the primary endpoint and demonstrated highly significant reductions in Lp(a) to week 36. Image courtesy: Silence Therapeutics christine.book Wed, 03/13/2024 - 13:00 March 13, 2024 — Silence Therapeutics has announced positive topline 36-week data from the ongoing ALPACAR-360 phase 2 study of zerlasiran ( SLN360 ) in 178 s
HCPLive
MARCH 13, 2024
April W. Armstrong, MD, MPH, discusses emerging therapies in oral systemics for the treatment of plaque psoriasis and shares developments in TYK2 inhibition.
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
Science Daily - Heart Disease
MARCH 13, 2024
Researchers from ETH Zurich and KUNO Klinik St. Hedwig in Regensburg have developed an algorithm that provides an automatic and reliable method of detecting a certain heart defect in newborns. Researchers from ETH Zurich and KUNO Klinik St. Hedwig in Regensburg have developed an algorithm that provides an automatic and reliable method of detecting a certain heart defect in newborns.
The New England Journal of Medicine
MARCH 13, 2024
A 55-year-old man had an out-of-hospital cardiac arrest. An evaluation showed 2-mm ST-segment elevations in the inferior leads on electrocardiography, cardiogenic shock, and a new systolic murmur. A diagnosis was made.
Nature Reviews - Cardiology
MARCH 13, 2024
Nature Reviews Cardiology, Published online: 14 March 2024; doi:10.1038/s41569-024-01010-4 Novel cardiovascular therapeutics have the potential to improve health outcomes, but financial toxicity from high out-of-pocket costs can limit the reach of these medications and worsen existing health disparities. Understanding the phenomenon of financial toxicity in treating cardiovascular disease is crucial to achieving health equity.
The New England Journal of Medicine
MARCH 13, 2024
In this podcast episode, host Lisa Rosenbaum talks with two trainees whose lives and careers have been changed by educational debt, and to an economist who has a rather different take on the problem.
Becker's Hospital Review - Cardiology
MARCH 13, 2024
Morristown, N.J.-based Atlantic Health System's Morristown Medical Center and New York City-based NYU Langone Health expanded their partnership to include adult congenital heart disease services.
American College of Cardiology
MARCH 13, 2024
Gilbert H. L. Tang, MD, MSc, MBA, FACC, has been selected as the next editor-in-chief of JACC: Case Reports. He will officially assume the role of editor-in-chief on Aug. 1, with his first issue slated for Aug. 7.
CardiacWire
MARCH 13, 2024
The hottest drug class in the world just got even hotter after the FDA approved Novo Nordisk’s weight-loss drug Wegovy for cardiovascular event risk reduction, opening new cardiology-focused routes for GLP-1 care and coverage. Wegovy’s expanded FDA approval now supports its use for the reduction of major adverse cardiovascular events in obese or overweight adults with established CVD.
HCPLive
MARCH 13, 2024
Alexis discusses clinical and demographic hurdles in treating skin of color for conditions like atopic dermatitis, and the potential of research like that being done in tapinarof cream 1%.
ADN Center of Excellence
MARCH 13, 2024
In the ever-changing environment of healthcare, one thing remains constant: the need for continuous learning and adaptation. The field of medicine is rapidly evolving, with new discoveries, technologies, and therapies arriving on a daily basis. In this blog, we'll focus at how continuing medical education is more than simply a professional requirement; it's also a catalyst for good change, altering healthcare throughout the world.
HCPLive
MARCH 13, 2024
Now, 4 years since the start of the pandemic, how has sleep been impacted? Sleep experts provide their perspective.
Frontiers in Cardiovascular Medicine
MARCH 13, 2024
Peripartum Cardiomyopathy (PPCM) is a polymorphic myocardial disease occurring late during pregnancy or early after delivery. While reduced systolic function and heart failure (HF) symptoms have been widely described, there is still a lack of reports about the arrhythmic manifestations of the disease. Most importantly, a broad range of unidentified pre-existing conditions, which may be missed by general practitioners and gynecologists, must be considered in differential diagnosis.
HCPLive
MARCH 13, 2024
A new study suggests a next-generation stool DNA test from Exact Sciences has improved sensitivity for colorectal cancer and precancerous lesions but lower specificity than FIT.
Med Page Today
MARCH 13, 2024
(MedPage Today) -- In certain patients with mild-to-moderate acute ischemic stroke, dual antiplatelet therapy (DAPT) with aspirin and clopidogrel (Plavix) reduced early neurologic deterioration better than aspirin alone, the Chinese randomized.
HCPLive
MARCH 13, 2024
Saeed Mohammed, MD, MS, discusses maralixibat for pruritus in PFIC, describing how IBAT inhibitors have changed the way clinicians are able to treat cholestatic liver disease.
Science Daily - Heart Disease
MARCH 13, 2024
Blockage of arterial blood vessels caused by atherosclerosis is largely responsible for heart attacks and strokes, which are the most common causes of death worldwide. The complex mechanisms that lead to pathological changes in the arteries are not yet fully understood. An international research team has now made important progress in understanding this disease and identified potential new approaches for early detection and therapy.
HCPLive
MARCH 13, 2024
In an interview with HCPLive, Daniel Karlin, MD, discussed how their phase 2B trial demonstrated MM120’s durability through week 12 for the treatment of generalized anxiety disorder.
NEJM Journal Watch - Cardiology
MARCH 13, 2024
In patients with angina and no obstructive coronary disease, positive stress tests were highly predictive of CMD.
HCPLive
MARCH 13, 2024
Treatment with DAA therapy at 3 years of age was associated with better health outcomes and cost savings versus deferring initiation to 6 years of age or older.
Society of Thoracic Surgeons - Congenital
MARCH 13, 2024
Event Heart Valve Disease Forum 2024 kchalko Wed, 03/13/2024 - 08:19 Event dates Aug 30–31, 2024 Mayfield Hotel, Seoul, Korea Location Seoul, Korea STS is pleased to co-present the Heart Valve Disease Forum (HVDF) with the Korean Society for Thoracic and Cardiovascular Surgery, offering the latest knowledge regarding the basics, diagnosis, treatment, and future of valvular heart disease.
Journal of Cardiothoracic Surgery
MARCH 13, 2024
Chest wall chondrosarcomas, although common, pose unique challenges due to their aggressive nature, rarity of abdominal wall involvement, and propensity for recurrence. We highlight the critical role of meticu.
Open Heart
MARCH 13, 2024
Objectives To describe the incidence of acute aortic dissection in a clearly defined population, to assess onset symptoms and admission biochemical marker levels and to analyse variables potentially associated to mortality. Methods Medical records and CT angiograms of all patients hospitalised for acute aortic dissection in the Stockholm County during the 5-year period 2012–2016 were reviewed.
HCPLive
MARCH 13, 2024
Iptacopan monotherapy improved hematologic outcomes in both anti-C5–treated patients with persistent anemia and those not treated with complement inhibitors across two phase 3 trials.
Open Heart
MARCH 13, 2024
Objective To investigate the time to first childbirth and to compare the prevalence of assisted reproductive treatment (ART) in women with congenital heart disease (CHD) compared with women without CHD. Methods All women in the national register for CHD who had a registered first childbirth in the Swedish Pregnancy Register between 2014 and 2019 were identified.
DAIC
MARCH 13, 2024
New Jersey-based Atlantic Health System’s Morristown Medical Center and New York-based NYU Langone Health, both nationally recognized cardiovascular programs, have announced that they are expanding their partnership to provide patients improved access to adult congenital heart disease services and the specialist directed care. Shown here, Trish O’Keefe, Senior Vice President, and President of Morristown Medical Center.
Open Heart
MARCH 13, 2024
Importance Although cardiac injury is a known complication of COVID-19 infection, there is no established tool to predict cardiac involvement and in-hospital mortality in this patient population. Objective To assess if left ventricular global longitudinal strain (LV-GLS) can detect cardiac involvement and be used as a risk-stratifying parameter for hospitalised patients with COVID-19.
HCPLive
MARCH 13, 2024
Dr April W. Armstrong reviews key findings from the phase 3 POETYK PSO-1 and POETYK PSO-2 clinical trials evaluating the use of deucravacitinib for the treatment of plaque psoriasis.
Physiologically Speaking
MARCH 13, 2024
Within exercise and sports science, no one measure has gotten more attention than VO2 max. VO2 max refers to your maximum rate of oxygen consumption, and it’s typically measured during a maximal exercise test to exhaustion (they’re not fun, trust me). It is used as an indicator of an individual's cardiorespiratory fitness and is often used to demonstrate the effects of training.
American College of Cardiology
MARCH 13, 2024
The goal of the ASCEND Aspirin trial was to evaluate aspirin compared with placebo among diabetics with no known cardiovascular disease (CVD).
HCPLive
MARCH 13, 2024
New data from the Family Heart Foundation highlights low access to PCSK9 inhibitors due to insurance rejections, despite guidelines recommending their use for high-risk patients.
American College of Cardiology
MARCH 13, 2024
In this week’s View, Dr. Eagle covers various blood pressure parameters and their predictability for peripheral arterial disease (PAD) and complications, then explores the five-year outcomes of leadless pacemakers.
Expert insights. Personalized for you.
115 
Let's personalize your content